Key Takeaway
Wegovy should be stopped at least two months before trying to conceive. Learn about its effects on fertility, weight loss benefits for reproduction, PCOS considerations, and contraception.
Wegovy (semaglutide 2.4 mg) should be stopped at least two months before you plan to become pregnant. The manufacturer's prescribing information is clear on this point. But the significant weight loss Wegovy provides can meaningfully improve fertility outcomes for patients whose reproductive health has been affected by excess weight. Balancing treatment timing with family planning is something to discuss with your provider early on.
Because Wegovy is specifically approved for chronic weight management, its patient population includes many women of childbearing age. Fertility questions are among the most frequently asked in clinical consultations for this medication.
Stopping Wegovy Before Pregnancy
Wegovy contains semaglutide at the 2.4 mg weekly dose, compounded formulations of the active ingredient found in Ozempic but at a higher concentration. Semaglutide has a half-life of approximately seven days, and the two-month discontinuation window allows the drug to clear through roughly eight half-life cycles.
Animal reproductive studies showed adverse fetal outcomes at high doses, including embryonic loss and developmental abnormalities. These findings occurred at exposures well above normal human doses, but because human pregnancy data is scarce, the precautionary washout period is strongly recommended.
Weight Loss and Reproductive Health Benefits
Wegovy produces average weight loss of approximately 15% of starting body weight in clinical trials. For patients whose fertility is compromised by obesity, this level of weight reduction can be significant: For a complete cost breakdown, see our compare GLP-1 providers.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- Hormonal balance improves as excess fat tissue (which produces estrogen) decreases
- Ovulatory function may resume in women with anovulatory cycles
- Insulin resistance decreases, supporting better reproductive hormone signaling
- Pregnancy complication risks (gestational diabetes, preeclampsia) are reduced at a healthier weight
- Assisted reproduction success rates tend to improve with lower BMI
Some fertility specialists now recommend a period of Wegovy-assisted weight loss followed by a washout window before patients begin active conception attempts or fertility treatments.
Unexpected Fertility Restoration
One of the most discussed aspects of GLP-1 medications and fertility is the unexpected return of ovulation. Women with longstanding PCOS or obesity-related anovulation may begin ovulating again as they lose weight on Wegovy, sometimes without realizing it. This has led to unplanned pregnancies in women who believed they were infertile.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →If you're taking Wegovy and don't wish to become pregnant, reliable contraception is important throughout treatment. Don't assume that past difficulty conceiving means you can't become pregnant while on this medication.
Contraception Considerations
Wegovy slows gastric emptying, which could theoretically reduce the absorption of oral contraceptive pills. While the clinical significance of this interaction isn't definitively established for semaglutide, some providers recommend using a non-oral backup method or switching entirely to a non-oral contraceptive during treatment. Options like hormonal IUDs, implants, and contraceptive injections bypass the GI tract entirely and are unaffected by gastric motility changes.
Frequently Asked Questions
How far in advance should I stop Wegovy before trying to conceive?
The manufacturer recommends stopping Wegovy at least two months before planned pregnancy. This ensures the medication is effectively cleared from your system. Your provider may suggest a personalized timeline based on your dose and overall health status.
Can Wegovy make you more fertile?
Indirectly, yes. The weight loss from Wegovy can restore hormonal balance, resume regular ovulation, and improve overall reproductive function. This is especially true for patients with obesity-related infertility or PCOS. The medication itself isn't a fertility drug, but its metabolic benefits can create conditions more favorable for conception.
What if I become pregnant while taking Wegovy?
Stop Wegovy immediately and notify your healthcare provider. The effects of early pregnancy exposure haven't been well studied in humans, so prompt discontinuation is the standard recommendation. Your provider will arrange appropriate follow-up and monitoring.
Does Wegovy affect male fertility?
Research on semaglutide's direct effects on male fertility is limited, but animal studies haven't shown significant concerns at therapeutic doses. The weight loss benefit is relevant for men as well: reducing obesity can improve testosterone levels, sperm quality, and overall reproductive function. Wegovy for weight loss
Is Wegovy safe to take while breastfeeding?
Wegovy isn't recommended during breastfeeding. It's unknown whether semaglutide passes into breast milk or what effects it could have on a nursing infant. If you're breastfeeding and want to use a weight management medication, discuss alternative options with your provider.